Abstract:Abstract Background Periodontal disease results in the breakdown of tissue and ultimately bone and tooth loss. The prevalence of periodontal disease in most countries exceeds 50% and is a direct contributor to a variety of systemic chronic diseases. In addition to bacterial pathogens there is evidence of fungal and viral pathogens having a role in the genesis of inflammation and release of cytokines that stimulate bone and tooth loss. Herpes viruses such as Epstein-Barr virus (EBV), Cytomegalovirus (CMV) and Herpes Simplex 1and 2 (HSV-1 and 2), are seen in less than 5% of normal periodontal tissues but in excess of 50% in severe periodontitis. Epithelial infection with Herpesviruses can lead to impaired and inappropriate immune responses that drive immune evasion and tissue destruction. Viral infection can also alter the expression of proteins in the infected tissues that result in enhanced adherence of bacterial species like Porphyromonas gingivalis and promote active systemic disease. This viral-bacterial synergism is a mechanism of severe disease and should be proactively monitored in dental and medical patients to reduce the burden of morbidity and mortality. Methods Several of the eight Herpesviruses have been shown to contribute to cardiovascular disease (CVD), Alzheimer’s, GI cancers and liver disease. Our laboratory has developed and implemented as an LDT, an RT-PCR assay that detects the presence of the Keystone bacterial pathogens (Porphyrmonas gingivalis [Pg], Fusobacterium nucleatum [Fn],Treponema denticola [Td], Tannerella forsythia [Tf] and Aggregatibacter actinomycetemcomitans [Aa]), Candida spp., Streptococcus spp. related to caries formation and four Herpesviruses (EBV, CMV, HSV 1 and 2). Results The major pathogenic determinants of severe periodontitis are active herpesviruses, presence of keystone bacterial species, and chronic production of proinflammatory cytokines (TNF-α, IL-1, IL-6). Data from more than 500 patients demonstrates the frequent presence of EBV and CMV in patients also infected with Pg, Td and Fn suggesting a synergism that promotes aggressive periodontitis. Conclusions The literature and our data argue for a proactive periodontal testing program that includes viral and bacterial targets to best address and mitigate periodontal disease and the reduce risks for chronic systemic diseases such as CVD, metabolic disease and neurodegenerative disease.

Herpes Viruses, Cytokines, And Altered Hemostasis In Vital Exhaustion

Herpesvirus Antibody Response and Occurrence of Symptoms in Acute and Post-Acute COVID-19 Disease

Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk

Disturbed Yin–Yang Balance: Stress Increases the Susceptibility to Primary and Recurrent Infections of Herpes Simplex Virus Type 1

Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection

Infections, Immunity, And Atherosclerosis - Associations Of Antibodies To Chlamydia Pneumoniae, Helicobacter Pylori, And Cytomegalovirus With Immune Reactions To Heat-Shock Protein 60 And Carotid Or Femoral Atherosclerosis

Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome

Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome

Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer

Infections, Immunity, and Atherosclerosis

Inflammation and reactivation of latent herpesviruses in older adults

Variability of changes in proand antiinflammatory cytokines due to IFNα and IFNγ deficiency in patients with post-covid syndrome associated with activation of chronic herpes viral infections

B-230 Rt-pcr detection and monitoring of infection in periodontal disease: a model of herpesviral-bacterial synergism

Antibodies to Human Herpesviruses and Rate of Incident Cardiovascular Events and All-Cause Mortality in the UK Biobank Infectious Disease Pilot Study

The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability

Vital exhaustion in chronic heart failure: symptom profiles and clinical outcome

HSV-1 and Cellular miRNAs in CSF-Derived Exosomes as Diagnostically Relevant Biomarkers for Neuroinflammation

Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

Herpesviruses in Etiopathogenesis of Aggressive Periodontitis: A Meta-Analysis Based on Case-Control Studies.